Hematologic Malignancy
T-Cell Proliferation of Uncertain Malignant Potential
CI-CAN-00000361Explore in graph →
HematologicNon-malignant3 active trials
- NCIt
- C27897
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000361Explore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06207812 | Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis | recruiting | — | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT03587844 | Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients | recruiting | Phase 2 | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT02840747 | Tissue Repository: CTCL Collection Protocol | recruiting | — | 400 | Columbia UniversityOTHER | 1 | Nov 4, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jul 16, 2026source: clinicaltrials